CESCA THERAPEUTICS ANNOUNCES COMPLIANCE WITH NASDAQ STOCK MARKET UNDER...
June 30, 2015
RANCHO CORDOVA, Calif – June 25, 2015 – Cesca Therapeutics, Inc. (NASDAQ:KOOL), an autologous ce...Read More >>
CESCA THERAPEUTICS REPORTS THIRD QUARTER FISCAL 2015 RESULTS
June 24, 2015
Company receives US FDA approval for its IDE Submission to the FDA for a Phase III Pivotal Clinical ...Read More >>